Vir Biotechnology, Inc.
VIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$163,141 | -$110,958 | -$120,965 | -$104,589 |
| Dep. & Amort. | $2,998 | $9,527 | $2,867 | $2,886 |
| Deferred Tax | $0 | $0 | $0 | -$2,643 |
| Stock-Based Comp. | $0 | $12,451 | $14,059 | $15,841 |
| Change in WC | -$20,601 | -$25,061 | $26,059 | -$17,001 |
| Other Non-Cash | $13,174 | -$6,178 | $0 | $17,871 |
| Operating Cash Flow | -$167,570 | -$120,219 | -$78,116 | -$87,635 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$317 | -$2,538 | -$1,629 | -$2,407 |
| Net Acquisitions | $37 | $0 | $0 | $0 |
| Inv. Purchases | -$264,447 | -$192,371 | -$173,694 | -$160,859 |
| Inv. Sales/Matur. | $305,173 | $251,320 | $301,860 | $301,136 |
| Other Inv. Act. | $0 | $45 | $281 | $2,867 |
| Investing Cash Flow | $40,446 | $56,456 | $126,818 | $140,737 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $101 | $2,406 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | -$360 | $598 | $1,263 |
| Financing Cash Flow | $102 | $2,046 | $598 | $1,263 |
| Forex Effect | -$1 | $0 | $0 | $0 |
| Net Chg. in Cash | -$127,023 | -$61,717 | $49,300 | $54,365 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $299,322 | $367,995 | $318,695 | $264,330 |
| End Cash | $172,299 | $306,278 | $367,995 | $318,695 |
| Free Cash Flow | -$167,887 | -$122,757 | -$79,745 | -$90,042 |